Updated:
Gossamer Bio, Inc.
Gossamer Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001728117, and its reported industry is...
Overview
Gossamer Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001728117, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-17, it reported annual revenue of USD 48,471,000; net income of USD -170,370,000; total assets of USD 172,249,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Gossamer Bio, Inc.
- Classification
- Public company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- San Diego, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- Ticker
- Nasdaq: GOSS
- SEC CIK
- 0001728117
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $48.5M | -$170.4M | $172.2M | $37.7M | -$171.3M | |
| FY2024USD | $114.7M | -$56.5M | $315.3M | $46.1M | -$3.5M | |
| FY2023USD | — | -$179.8M | $311.9M | $32.1M | -$159.2M | |
| FY2022USD | — | -$229.4M | $272.4M | $112.0M | -$187.0M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Gossamer Bio, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.